A detailed history of Cullen Investment Group, Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 42,677 shares of PFE stock, worth $1.06 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
42,677
Previous 42,300 0.89%
Holding current value
$1.06 Million
Previous $1.18 Billion 4.35%
% of portfolio
0.18%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$27.7 - $31.39 $10,442 - $11,834
377 Added 0.89%
42,677 $1.24 Billion
Q2 2024

Jul 01, 2024

SELL
$25.26 - $29.6 $86,389 - $101,232
-3,420 Reduced 7.48%
42,300 $1.18 Billion
Q1 2024

Apr 04, 2024

SELL
$25.89 - $29.73 $150,861 - $173,236
-5,827 Reduced 11.3%
45,720 $1.26 Billion
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $1.35 Million - $1.75 Million
51,547 New
51,547 $1.48 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cullen Investment Group, Ltd. Portfolio

Follow Cullen Investment Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Investment Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Cullen Investment Group, Ltd. with notifications on news.